Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/88b5dffda1124385a9d172a7073bce20 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:88b5dffda1124385a9d172a7073bce20 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:88b5dffda1124385a9d172a7073bce202021-11-21T08:30:05ZPhase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival10.1136/jitc-2021-0024722051-1426https://doaj.org/article/88b5dffda1124385a9d172a7073bce202021-09-01T00:00:00Zhttps://jitc.bmj.com/content/9/9/e002472.fullhttps://doaj.org/toc/2051-1426Hui ZhengEirini PectasidesMohamed UdumanCharles S FuchsJames M ClearyAdam J BassJérémy AugustinLeonie K de KlerkAnuj K PatelSarah DerksNihal RamanFahire G AkarcaNadine J McClearyDouglas A RubinsonJeffrey W ClarkBridget FitzpatrickLauren K BraisMegan E CavanaughAmanda J RodeMelissa G JeanPatrick H LizotteMatthew J NazzaroPeter C EnzingerBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Hui Zheng Eirini Pectasides Mohamed Uduman Charles S Fuchs James M Cleary Adam J Bass Jérémy Augustin Leonie K de Klerk Anuj K Patel Sarah Derks Nihal Raman Fahire G Akarca Nadine J McCleary Douglas A Rubinson Jeffrey W Clark Bridget Fitzpatrick Lauren K Brais Megan E Cavanaugh Amanda J Rode Melissa G Jean Patrick H Lizotte Matthew J Nazzaro Peter C Enzinger Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival |
| format |
article |
| author |
Hui Zheng Eirini Pectasides Mohamed Uduman Charles S Fuchs James M Cleary Adam J Bass Jérémy Augustin Leonie K de Klerk Anuj K Patel Sarah Derks Nihal Raman Fahire G Akarca Nadine J McCleary Douglas A Rubinson Jeffrey W Clark Bridget Fitzpatrick Lauren K Brais Megan E Cavanaugh Amanda J Rode Melissa G Jean Patrick H Lizotte Matthew J Nazzaro Peter C Enzinger |
| author_facet |
Hui Zheng Eirini Pectasides Mohamed Uduman Charles S Fuchs James M Cleary Adam J Bass Jérémy Augustin Leonie K de Klerk Anuj K Patel Sarah Derks Nihal Raman Fahire G Akarca Nadine J McCleary Douglas A Rubinson Jeffrey W Clark Bridget Fitzpatrick Lauren K Brais Megan E Cavanaugh Amanda J Rode Melissa G Jean Patrick H Lizotte Matthew J Nazzaro Peter C Enzinger |
| author_sort |
Hui Zheng |
| title |
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival |
| title_short |
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival |
| title_full |
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival |
| title_fullStr |
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival |
| title_full_unstemmed |
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival |
| title_sort |
phase ii study of pembrolizumab in refractory esophageal cancer with correlates of response and survival |
| publisher |
BMJ Publishing Group |
| publishDate |
2021 |
| url |
https://doaj.org/article/88b5dffda1124385a9d172a7073bce20 |
| work_keys_str_mv |
AT huizheng phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT eirinipectasides phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT mohameduduman phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT charlessfuchs phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT jamesmcleary phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT adamjbass phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT jeremyaugustin phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT leoniekdeklerk phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT anujkpatel phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT sarahderks phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT nihalraman phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT fahiregakarca phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT nadinejmccleary phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT douglasarubinson phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT jeffreywclark phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT bridgetfitzpatrick phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT laurenkbrais phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT meganecavanaugh phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT amandajrode phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT melissagjean phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT patrickhlizotte phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT matthewjnazzaro phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival AT petercenzinger phaseiistudyofpembrolizumabinrefractoryesophagealcancerwithcorrelatesofresponseandsurvival |
| _version_ |
1718419376351215616 |